Kunzer; Hermann

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kunzer; Hermann.The latest application filed is for "pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases".

Company Profile

0.7.8

Kunzer; Hermann - Berlin DE
Kunzer; Hermann - Reinsfeld DE
KUNZER; Hermann - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
BET protein-inhibiting 5-aryltriazoleazepines Grant 9,663,523 - Schmees , et al. May 30, 2	2017-05-30
N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products Grant 9,428,460 - Nguyen , et al. August 30, 2	2016-08-30
Pyrrolo- And Pyrazolo-triazolodiazepines As Bet-protein Inhibitors For Treating Hyperproliferative Diseases App 20160009725 - SCHMEES; Norbert ; et al.	2016-01-14
4-substituted Pyrrolo- And Pyrazolo-diazepines App 20150376196 - SCHMEES; Norbert ; et al.	2015-12-31
Bet Protein-inhibiting 5-aryl Triazole Azepines App 20150299201 - Schmees; Norbert ; et al.	2015-10-22
N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products App 20150191431 - Nguyen; Duy ; et al.	2015-07-09
Compounds for binding and imaging amyloid plaques and their use App 20120237446 - Rohn; Ulrike ; et al.	2012-09-20
17Beta-Alkyl-17Alpha-oxy-estratrienes App 20120157421 - Bohlmann; Rolf ; et al.	2012-06-21
Tetrahydronaphthalenylamides, A Process For Their Production And Their Use As Anti-inflammatory Agents App 20080200519 - BERGER; Markus ; et al.	2008-08-21
11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11.beta.-HALOGEN-7.alpha.-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS Grant 6,780,855 - Bohlmann , et al. August 24, 2	2004-08-24
11beta-halogen-7alpha-substituted Estratrienes, Metod For Producing Pharmaceutical Preparations Containing Said 11beta-halogen-7alpha- Substituted Estratrienes And Use Of The Same For Producing Medicaments App 20030069434 - BOHLMANN, ROLF ; et al.	2003-04-10
7.alpha.-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents Grant 6,271,403 - Bohlmann , et al. August 7, 2	2001-08-07
7.alpha.-(.xi.-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7.alpha.-(.xi.-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents Grant 5,866,560 - Bohlmann , et al. February 2, 1	1999-02-02
Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents Grant 5,807,899 - Bohlmann , et al. September 15, 1	1998-09-15
11.beta.-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents Grant 5,502,046 - Bohlmann , et al. March 26, 1	1996-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.